A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume

Conditions

• Bloodloss
• Surgical Procedures, Operative

Interventions

• DRUG: ecallantide
• DRUG: placebo

Sponsor

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)